Scalper1 News
Big pharma AbbVie beat analysts’ Q3 estimates and raised its guidance Friday, sending its stock up 4% to an all-time high above 63. AbbVie’s (ABBV) earnings rose 9% over the year-earlier quarter to 89 cents a share, 12 cents above analysts’ consensus, according to Thomson Reuters. Sales increased 8% to just over $5 billion, beating estimates by nearly $200 million. The company lifted its full-year guidance by 20 cents to a range of $3.25 to $3.27, Scalper1 News
Scalper1 News